Clinical characterization of insulin secretion as the basis for genetic analyses

Diabetes

Volumn 51, Issue SUPPL., 2002, Pages

  Stumvoll, Michael ^a   Fritsche, Andreas ^a   Häring, Hans Ulrich ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUCAGON LIKE PEPTIDE 1;

CELL HETEROGENEITY; CONFERENCE PAPER; DIABETES MELLITUS; DNA POLYMORPHISM; FAMILY HISTORY; GENETIC ANALYSIS; GENETIC VARIABILITY; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0036311031     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.2007.s122     Document Type: Conference Paper

References (35)

1. Insulin action, diabetogenes, and the cause of type II diabetes
2. Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM)
3. The genetics of obesity in humans
4. Pathogenesis of non-insulin-dependent diabetes mellitus
5. Type II diabetes: Clinical aspects of molecular biological studies
6. Molecular physiology and genetics of NIDDM: Importance of metabolic staging
7. Molecular genetics of diabetes mellitus
8. Insulin sensitivity and insulin secretion in monozygotic and dizygotic twins
9. Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects: Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests
10. Monogenic diabetes mellitus in youth: The MODY syndromes
11. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence
12. Missense mutations in the human insulin promoter factor-1 gene and their relation to maturity-onset diabetes of the young and late-onset type 2 diabetes mellitus in Caucasians
13. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus
14. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes
15. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
16. Calpain 10: The first positional cloning of a gene for type 2 diabetes
17. Disruption of IRS-2 causes type 2 diabetes in mice
18. The Gly972→Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells
19. A novel hyperglycemic clamp for characterization of islet function in humans: Assessment of three different secretagogues, maximal insulin response and reproducibility
20. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus
21. Role of insulin resistance in the pathogenesis of NIDDM
22. Concordance rate for type II diabetes mellitus in monozygotic twins: Actuarial analysis
23. Empirical risk figures for first-degree relatives of non-insulin-dependent diabetics
24. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes
25. The pathogenesis of GDM: Implications for diabetes after pregnancy
26. Non-insulin-dependent diabetes mellitus and gestational diabetes mellitus. Same disease, another name?
27. UKPDS 19: Heterogeneity in NIDDM: Separate contributions of IRS-1 and beta 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations: UK Prospective Diabetes Study
28. Amino acid polymorphism Gly 972 Arg in IRS-1 is not associated to lower clamp-derived insulin sensitivity in young healthy first degree relatives of patients with type 2 diabetes
29. Insulin receptor substrate (IRS-1) gene polymorphisms in French NIDDM families
30. Expression of variant forms of insulin receptor substrate-1 identified in patients with noninsulin-dependent diabetes mellitus
31. Molecular scanning of the insulin receptor substrate-1 (IRS-1) gene in Japanese patients with NIDDM: Identification of five novel polymorphisms
32. Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus
33. Insulin receptor substrate-1 variants in non-insulin-dependent diabetes
34. Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and β-cell dysfunction
35. Characterisation of beta-cell dysfunction of impaired glucose tolerance: Evidence for impairment of incretin-induced insulin secretion